Beclin 2 activators comprise a range of chemical compounds that influence various cellular pathways to enhance the functional activity of beclin 2. Lithium carbonate, for example, has a significant influence on the autophagic pathway by reducing the levels of inositol, thereby potentiating beclin 2's role in the initiation of autophagy. Rapamycin, a well-known autophagy inducer, binds with FKBP12 to inhibit mTOR, which is a negative regulator of autophagy. This inhibition leads to the upregulation of autophagy and subsequent activation of beclin 2. Similarly, carbamazepine achieves an enhancement of beclin 2 activity by inducing autophagy via inositol synthesis inhibition. Perhexiline's effect on lipid metabolism and subsequent influence on autophagy-related lipid processes also implicates a role for enhancing beBeclin 2 activators comprise a range of chemical compounds that influence various cellular pathways to enhance the functional activity of beclin 2. Lithium carbonate, for example, has a significant influence on the autophagic pathway by reducing the levels of inositol, thereby potentiating beclin 2's role in the initiation of autophagy. Rapamycin, a well-known autophagy inducer, binds with FKBP12 to inhibit mTOR, which is a negative regulator of autophagy. This inhibition leads to the upregulation of autophagy and subsequent activation of beclin 2. Similarly, carbamazepine achieves an enhancement of beclin 2 activity by inducing autophagy via inositol synthesis inhibition. Perhexiline's effect on lipid metabolism and subsequent influence on autophagy-related lipid processes also implicates a role for enhancing beclin 2.
Other compounds like spermidine and resveratrol function through epigenetic and sirtuin-related pathways, respectively, to promote autophagy, which could enhance the activity of beclin 2. Metformin, a widely used antidiabetic drug, upregulates AMPK, leading to the inhibition of the mTOR pathway and fostering an environment for autophagy, where beclin 2's function is vital. Nicotinamide, which affects sirtuin-mediated deacetylation, has implications for autophagic processes that involve beclin 2 as well. Moreover, trehalose and salicylate, through their respective mechanisms, have the potential to activate autophagy, thereby boosting beclin 2 activity. Curcumin, known for its wide-ranging effects on cellular pathways, can potentiate autophagy via the inhibition of AKT/mTOR signaling, which may have implications for beclin 2 activity enhancement. Lastly, 2-deoxy-D-glucose creates a cellular environment that mimics energy shortage, thereby activating AMPK and autophagy, processes critical for beclin 2 activity.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can upregulate autophagy through multiple pathways, including the inhibition of the AKT/mTOR pathway, which may lead to an enhancement of beclin 2 activity. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-DG is a glucose analog that can inhibit glycolysis and induce a cellular energy crisis, leading to the activation of AMPK and subsequent autophagy, potentially enhancing beclin 2's activity. | ||||||